Vitaly joined atai Life Sciences in 2021. Previously, Vitaly was a Program Lead at the Gates Medical Research Institute where he was responsible for the product strategy & development, supporting clinical trials, regulatory submissions, due diligence efforts, and partnerships management.
Prior to that, he spent 18 years in the Biotech/Pharma industry at a number of companies (Boehringer Ingelheim, Pfizer BioPharma, Alnylam, KaryoPharm, Epizyme) as well as venture-backed biotech startups where he was responsible for the program leadership, portfolio management, strategy development, and execution. Additionally, Vitaly is a part of the biotech angel group focused on assessing and investing in breakthrough technologies.
Vitaly holds a Master’s degree in Analytical Chemistry, MBA as well as completed executive leadership courses at Harvard Kennedy School of Government.